Xenon Inhalation for Treatment of Posttraumatic Stress Disorder

Clinical trial NCT03635827 · UNKNOWN

Trial details

NCT number: NCT03635827
Sponsor: Nobilis Therapeutics Inc.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Post Traumatic Stress Disorder

Start date: 2021-06-01
Primary completion: 2021-06-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.